Literature DB >> 1748275

Diabetic embryopathy. Studies with animal and in vitro models.

U J Eriksson1, L A Borg, H Forsberg, J Styrud.   

Abstract

Diabetic pregnancy is associated with an increased risk for fetal maldevelopment for a largely unknown reason. A decade ago, Norbert Freinkel suggested that the altered fuel mixture offered to the growing conceptus may be the key to most of the changes in the embryogenesis of diabetic pregnancy. He coined the term fuel-mediated teratogenesis. During early pregnancy, periods of maternal hyper- and hypoglycemia may cause marked changes in the availability of glucose to the conceptus. Also, increased concentrations of lipids, notably ketone bodies, and branched-chain amino acids in the maternal circulation contribute to a changed fuel mixture for the embryo. In a recent experimental study of diabetic rats, it was found that the maternal metabolism of all three major classes of nutrients and maternal somatic growth during gestation covaried with the development of the embryo. Consequently, the maintenance of normal concentrations of metabolites from all nutrient classes may be important for prevention of adverse fetal outcome in diabetic pregnancy. In vitro, a high glucose concentration causes embryonic dysmorphogenesis by generation of free oxygen radicals. An enhanced production of such radicals in embryonic tissues may be directly related to an increased risk of congenital malformations in diabetic pregnancy. Thus, the notion that alterations in the net transfer of cellular fuels from the diabetic mother to her offspring may cause embryonic dysmorphogenesis, which suggests that combustion of the fuel may produce compounds that impair embryonic development, has obtained experimental support. If this is also true for human diabetic pregnancy, it has therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748275     DOI: 10.2337/diab.40.2.s94

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Diabetic embryopathy: a role for the epigenome?

Authors:  J Michael Salbaum; Claudia Kappen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-02

3.  Scintigraphic evaluation of small intestinal transit in the streptozotocin induced diabetic rats.

Authors:  G Durmus-Altun; U Vatansever; S Arzu Vardar; S Altaner; B Dirlik
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

4.  Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E.

Authors:  M Viana; E Herrera; B Bonet
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

5.  Bcl-2 expression in a diabetic embryopathy model in presence of polyamines.

Authors:  Gladys Chirino-Galindo; D Eber Hernández-Hernández; L Coral Reyes-Mateos; Ricardo Mejía-Zepeda; Martha Martínez-García; Martín Palomar-Morales
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-19       Impact factor: 2.416

6.  Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation.

Authors:  E Pinter; J Haigh; A Nagy; J A Madri
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

7.  Dynamic glucoregulation and mammalian-like responses to metabolic and developmental disruption in zebrafish.

Authors:  Agata Jurczyk; Nicole Roy; Rabia Bajwa; Philipp Gut; Kathryn Lipson; Chaoxing Yang; Laurence Covassin; Waldemar J Racki; Aldo A Rossini; Nancy Phillips; Didier Y R Stainier; Dale L Greiner; Michael A Brehm; Rita Bortell; Philip diIorio
Journal:  Gen Comp Endocrinol       Date:  2010-10-20       Impact factor: 2.822

8.  Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: correlation with PECAM-1/CD31 tyrosine phosphorylation state.

Authors:  E Pinter; S Mahooti; Y Wang; B A Imhof; J A Madri
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

9.  Diabetes-induced fetal growth retardation is associated with suppression of NF-kappaB activity in embryos.

Authors:  Keren Mammon; Rotem Keshet; Shoshana Savion; Olga Pekar; Zeev Zaslavsky; Amos Fein; Vladimir Toder; Arkady Torchinsky
Journal:  Rev Diabet Stud       Date:  2005-05-10

10.  Effects of alpha-lipoic acid supplementation on maternal diabetes-induced growth retardation and congenital anomalies in rat fetuses.

Authors:  M H M Al Ghafli; R Padmanabhan; H H Kataya; B Berg
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.